Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

NCT00895882 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic Genotype 1 Hepatitis C Virus Infection

Interventions

DRUG: vaniprevir (MK7009)
DRUG: Comparator: vaniprevir (MK7009)
DRUG: Comparator: Pegylated Interferon (peg-IFN) alfa-2a
DRUG: Comparator: Ribavirin
DRUG: Comparator: Placebo to vaniprevir

Sponsor

Merck Sharp & Dohme LLC